KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Shares Outstanding
Others
Ratios

AbCellera Biologics (ABCL) Depreciation & Amortization - Total (2022 - 2023)

Historic Depreciation & Amortization - Total for AbCellera Biologics (ABCL) over the last 2 years, with Q4 2023 value amounting to $3.9 million.

  • AbCellera Biologics' Depreciation & Amortization - Total rose 3988.52% to $3.9 million in Q4 2023 from the same period last year, while for Sep 2024 it was $3.9 million, marking a year-over-year decrease of 6691.55%. This contributed to the annual value of $12.5 million for FY2024, which is 205.47% down from last year.
  • Per AbCellera Biologics' latest filing, its Depreciation & Amortization - Total stood at $3.9 million for Q4 2023, which was up 3988.52% from $3.1 million recorded in Q3 2023.
  • AbCellera Biologics' 5-year Depreciation & Amortization - Total high stood at $3.9 million for Q4 2023, and its period low was $1.4 million during Q1 2022.